29.05.2015 16:40:00

GlaxoSmithKline LLC -- Moody's changes outlook on GSK's A2 issuer rating to negative

Frankfurt am Main, May 29, 2015 -- Moody's Investors Service has today affirmed GlaxoSmithKline plc's (GSK) A2 long-term issuer rating and (P) P-1 short-term rating and changed the outlook of GSK to negative from stable reflecting the rating agency's view that over the next 2 or 3 years GSK may find it difficult to restore credit metrics in line with our expectations for the current rating.

Vollständigen Artikel bei Moodys lesen